{
    "clinical_study": {
        "@rank": "9881", 
        "arm_group": {
            "arm_group_label": "detection of circulating tumors cells", 
            "description": "This prospective, single-institution study conducted at the University Hospital Hamburg-Eppendorf (Hamburg, Germany) enrolled 123 patients with ECs that were initially considered resectable. Only patients with histologically proven EC were included. Peripheral blood samples for CTC analysis were collected immediately before surgery."
        }, 
        "brief_summary": {
            "textblock": "Despite the availability of several preoperative diagnostic techniques, accurate\n      pretreatment staging of esophageal cancer (EC) remains challenging. Therefore, The\n      investigators evaluated the prognostic significance of circulating tumor cells (CTCs) in\n      patients with EC."
        }, 
        "brief_title": "Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Resectable Esophageal Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Esophageal Neoplasms", 
                "Neoplastic Cells, Circulating"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  > 18 years\n\n          -  resectable esophageal cancer\n\n        Exclusion Criteria:\n\n          -  < 18 years\n\n          -  esophageal cancer with preoperative distant metastases"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "This prospective, single-institution study conducted at the University Hospital\n        Hamburg-Eppendorf (Hamburg, Germany) enrolled 123 patients with ECs that were initially\n        considered resectable."
            }
        }, 
        "enrollment": {
            "#text": "123", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01858805", 
            "org_study_id": "CTC-EC", 
            "secondary_id": "184"
        }, 
        "intervention": {
            "arm_group_label": "detection of circulating tumors cells", 
            "intervention_name": "esophagectomy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "esophagus carcinoma", 
            "surgery", 
            "circulating tumor cells"
        ], 
        "lastchanged_date": "May 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hamburg", 
                    "country": "Germany", 
                    "zip": "20246"
                }, 
                "name": "University Hospital Hamburg-Eppendorf"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Ministry of Education and Research", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "overall survival", 
            "safety_issue": "Yes", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01858805"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universit\u00e4tsklinikum Hamburg-Eppendorf", 
            "investigator_full_name": "Dr. med. Matthias Reeh", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "recurrence-free survival", 
            "safety_issue": "Yes", 
            "time_frame": "2 years"
        }, 
        "source": "Universit\u00e4tsklinikum Hamburg-Eppendorf", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universit\u00e4tsklinikum Hamburg-Eppendorf", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2013"
    }
}